Date: Monday 02 Apr 2012
Drugs giant GlaxoSmithKline is to increase its stake in US biopharmaceutical company Theravance.
| Question marks remain over Glaxo drug Relovair | 09-Jan-2012 | ShareCast |
No recent information was found.
No recent information was found.
| GlaxoSmithKline and Theravance Announce Start of... | 03-Jan-2008 | PR Newswire |
| Astellas and Theravance Report Additional Telava... | 18-Sep-2007 | PR Newswire |
| Currency | US Dollars |
| Share Price | $ 22.02 |
| Change Today | $ 0.19 |
| % Change | 0.87 % |
| 52 Week High | $26.13 |
| 52 Week Low | $16.39 |
| Volume | 258,606 |
| Shares Issued | 86.54m |
| Market Cap | $1,905.66m |
| Beta | 1.68 |
| RiskGrade | 261 |
| Strong Buy | 6 |
| Buy | 1 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 11 |

| Time | Volume / Share Price |
| 16:00 | 18,270 @ $22.02 |
| 15:59 | 200 @ $22.05 |
| 15:59 | 400 @ $22.04 |
| 15:59 | 258 @ $22.05 |
| 15:59 | 100 @ $22.05 |
You are here: research